Profluent, Lilly Partner to Advance AI Gene Editing Tech
EMERYVILLE, CALIFORNIA, April 29, 2026 Profluent has announced a strategic multi-program research collaboration with Eli Lilly and Company to...
genetic medicine
Advertisement
Eli Lilly to Acquire Kelonia for In Vivo CAR-T Breakthrough
INDIANAPOLIS and BOSTON, Mass., April 20, 2026 Eli Lilly and Company has announced a landmark agreement to acquire Kelonia...
Dyno AI Capsid Licensed by Astellas for Gene Therapy
WATERTOWN, Mass., April 8, 2026 Dyno Therapeutics, Inc. has announced that Astellas Pharma has exercised its option to license...
Sarepta Reports Breakthrough siRNA Data in FSHD, DM1
CAMBRIDGE, Massachusetts, March 25, 2026 Sarepta Therapeutics has announced first clinical data from its next-generation siRNA pipeline, demonstrating robust...
Novartis Closes $12B Avidity Acquisition
BASEL, Switzerland – February 27, 2026 Novartis AG has successfully completed its acquisition of Avidity Biosciences, Inc., strengthening its...
Advertisements
Sensorion Secures €60M to Advance Gene Therapies for Hearing Loss
MONTPELLIER, France | January 28, 2026 — Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, announced a...
Roche Launches Rapid 15-Minute Bordetella Point-of-Care Test
Basel, Switzerland, December 2, 2025 —Roche has announced the launch of a rapid 15-minute point-of-care PCR test capable of...
Regeneron and Tessera Unite to Develop TSRA-196 Therapy
Tarrytown, New York & Somerville, Massachusetts, December 1, 2025 — Regeneron and Tessera Therapeutics have announced a global collaboration...
Wave Life Sciences Advances RNA Innovation Ahead of Q3 2025 Results
CAMBRIDGE, Mass., November 4, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company pioneering the use...
Solid Biosciences Licenses AAV-SLB101 Capsid to Advance Gene Therapies
CHARLESTOWN, Mass., Sept. 23, 2025 — Solid Biosciences has entered a non-exclusive licensing agreement with Kinea Bio to utilize...
Advertisement
